Application of recombinant human cytoglobin in preparation of drugs treating hyperlipidemia and atherosclerosis

A technology for atherosclerosis and hyperlipidemia, applied in the field of application of recombinant human cytoglobin in the preparation of drugs for treating hyperlipidemia and atherosclerosis
CN104096218AActive Publication Date: 2014-10-15θ‘£ζ–‡ε…Ά
7 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Current Assignee / Owner
θ‘£ζ–‡ε…Ά
Publication Date
2014-10-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses application of recombinant human cytoglobin (rhCYGB) in preparation of drugs treating hyperlipidemia and atherosclerosis. A hyperlipidemia rat model and an atherosclerosis rat model are respectively established by the inventor, and subcutaneous injection of rhCYGB is carried out for treatment. Experimental results show that the rhCYGB drug is non-toxic, compared with a model control group, the rhCYGB treatment group has significant improvement, the four items of blood lipid test are significantly decreased than those of a model group, and the four items of blood lipid test of a polysaccharide sulfate treatment group are significantly higher than normal, thus rhCYGB has better efficacy than polysaccharide sulfate in treatment of hyperlipidemia caused by high fat diet. In the atherosclerosis rat model, compared with the model group, the four items of blood lipid test of the treatment group are also significantly reduced, and atherosclerotic plaques also obviously decreased. Therefore, treatment of hyperlipidemia and atherosclerosis by the recombinant human cytoglobin has the advantages of low toxicity, safety and effectiveness.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a new application of recombinant human cell globin, in particular to the application of recombinant human cell globin in the preparation of drugs for treating hyperlipidemia and atherosclerosis. Background technique

[0002] According to relevant reports, hyperlipidemia is closely related to the occurrence and development of atherosclerosis. The main harm of hyperlipidemia is to cause atherosclerosis, which in turn leads to many related diseases, the most common fatal disease is coronary heart disease. Angina pectoris, myocardial infarction, stroke, renal insufficiency, and hemiplegia complicated by atherosclerosis are often the main causes of death in middle-aged and elderly patients. Many doctors believe that effective treatment of hyperlipidemia is very beneficial to prevent the occurrence of atherosclerosis.

[0003] Hyperlipidemia is characterized by abnormal fat metabolism or operation, which makes the content of one or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More